T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$2.48B |
| 2 |
Kenvue
KVUE
|
+$1.5B |
| 3 |
Halliburton
HAL
|
+$1.12B |
| 4 |
Boeing
BA
|
+$950M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$920M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.64B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Advanced Micro Devices
AMD
|
+$1.66B |
| 4 |
Johnson & Johnson
JNJ
|
+$1.56B |
| 5 |
Amazon
AMZN
|
+$1.17B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.76% |
| 2 | Healthcare | 16.83% |
| 3 | Financials | 10.91% |
| 4 | Consumer Discretionary | 10.77% |
| 5 | Communication Services | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2701
US Global Investors
GROW
$38.7M
| $77K | ﹤0.01% |
26,700
| – | – |
|
|
PRPH
2702
DELISTED
ProPhase Labs
PRPH
| $76K | ﹤0.01% |
1,730
| – | – |
|
2703
Nektar Therapeutics
NKTR
$2.55B
| $75K | ﹤0.01% |
8,317
+3,874
| +87% | +$37.3K |
|
2704
Solid Power
SLDP
$543M
| $75K | ﹤0.01% |
36,636
+4,677
| +15% | +$11.1K |
|
2705
PDS Biotechnology
PDSB
$13.2M
| $74K | ﹤0.01% |
14,587
| – | – |
|
2706
NuScale Power
SMR
$4B
| $74K | ﹤0.01% |
14,819
+3,952
| +36% | +$26.1K |
|
2707
Zymeworks
ZYME
$1.8B
| $74K | ﹤0.01% |
11,561
+739
| +7% | +$5.46K |
|
|
CONN
2708
DELISTED
Conn's Inc.
CONN
| $74K | ﹤0.01% |
18,700
| – | – |
|
2709
Personalis
PSNL
$1.51B
| $73K | ﹤0.01% |
60,100
| – | – |
|
2710
XBiotech
XBIT
$71.6M
| $73K | ﹤0.01% |
17,600
| – | – |
|
|
NVTA
2711
DELISTED
Invitae Corporation
NVTA
| $73K | ﹤0.01% |
119,323
-64,031
| -35% | -$66.5K |
|
|
FIRY
2712
Firy Inc
FIRY
$160M
| $72K | ﹤0.01% |
+13,992
| New | +$124K |
|
|
AHT
2713
Ashford Hospitality Trust
AHT
$20.3M
| $71K | ﹤0.01% |
2,970
+1,240
| +72% | +$39.3K |
|
|
BLUE
2714
DELISTED
bluebird bio
BLUE
| $71K | ﹤0.01% |
1,160
-1,006
| -46% | -$70.7K |
|
2715
Fulcrum Therapeutics
FULC
$280M
| $71K | ﹤0.01% |
15,900
-5,300
| -25% | -$23.2K |
|
2716
Nano X Imaging
NNOX
$72.5M
| $71K | ﹤0.01% |
+10,707
| New | +$110K |
|
2717
FTAI Infrastructure
FIP
$540M
| $70K | ﹤0.01% |
21,720
+1,638
| +8% | +$5.66K |
|
|
MCW
2718
DELISTED
Mister Car Wash
MCW
| $70K | ﹤0.01% |
12,688
+1,158
| +10% | +$8.84K |
|
2719
RUM Group Inc
RUM
$4B
| $70K | ﹤0.01% |
+13,700
| New | +$102K |
|
2720
Akebia Therapeutics
AKBA
$254M
| $69K | ﹤0.01% |
59,900
-22,900
| -28% | -$29.4K |
|
|
ONL
2721
Orion Office REIT
ONL
$161M
| $69K | ﹤0.01% |
13,092
+1,226
| +10% | +$7.44K |
|
2722
Angi Inc
ANGI
$178M
| $68K | ﹤0.01% |
3,400
| – | – |
|
2723
Aqua Metals
AQMS
$9.78M
| $68K | ﹤0.01% |
299
| – | – |
|
|
FFWM
2724
DELISTED
First Foundation Inc
FFWM
| $68K | ﹤0.01% |
+11,147
| New | +$73.5K |
|
2725
Purple Innovation
PRPL
$28.3M
| $68K | ﹤0.01% |
1,584
+47
| +3% | +$2.93K |
|
Similar funds
T. Rowe Price Associates's Q3 2023 Portfolio in Review
As of Q3 2023, T. Rowe Price Associates held 2,959 positions worth $682B, down 4.9% from $718B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Trading was light in Q3 2023: portfolio turnover was 4.7%. T. Rowe Price Associates opened 69 new positions and exited 71, leaving the 2,959-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q3 2023 buy was Maplebear: 6,435,942 shares worth $191M.
- T. Rowe Price Associates added most to SLB Ltd in Q3 2023, an estimated $2.48B increase.
- T. Rowe Price Associates's biggest Q3 2023 reduction was Microsoft, cutting an estimated $2.64B.
- T. Rowe Price Associates fully exited Life Storage, Inc. in Q3 2023, selling an estimated $285M.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $682B portfolio in Q3 2023.
- T. Rowe Price Associates opened 69 new positions and closed 71 in Q3 2023.
- T. Rowe Price Associates's portfolio value fell 4.9% quarter-over-quarter to $682B.
Based on T. Rowe Price Associates's 13F filing for Q3 2023, filed 14 Nov 2023.